Has Joe Rogan confirmed using testosterone replacement therapy?

Yes. Rogan has confirmed TRT use in multiple episodes of The Joe Rogan Experience, dating back to at least 2013. He has described it as a medically supervised decision made after blood work showed declining testosterone levels.

What testosterone dose would a clinician typically prescribe for a man Rogan's age?

For a man in his mid-50s with confirmed low testosterone, standard dosing is 100 to 200 mg of testosterone cypionate or enanthate per week, split into two injections. The target is typically 600 to 900 ng/dL on trough blood draws, per Endocrine Society guidelines.

Is BPC-157 FDA-approved?

No. BPC-157 is not FDA-approved for any indication. All published efficacy data comes from animal studies. It is available through compounding pharmacies, but quality and purity vary. The FDA has flagged concerns about compounded peptide products.

What are the main risks of long-term TRT?

Polycythemia (elevated red blood cell count), suppression of natural testosterone production and fertility, potential cardiovascular effects (data is mixed), and estrogen-related side effects if aromatase activity is not managed. Regular lab monitoring is required.

Does Rogan use ipamorelin?

Rogan has discussed growth-hormone-releasing peptides including ipamorelin during podcast conversations with guests. He has not explicitly confirmed personal use of ipamorelin specifically.

What Joe Rogan's Reported Protocol Might Look Like Clinically

By HealthRX Medical Team

Published May 25, 2026Updated May 25, 2026Last reviewed May 25, 2026

The Public Record: What Rogan Has Actually Said

Joe Rogan's relationship with TRT is not speculated. It is confirmed, repeatedly and on the record. He first discussed testosterone replacement on The Joe Rogan Experience in conversations dating back to the early 2010s, and he has revisited the topic with guests including Dr. Andrew Huberman, Dr. Peter Attia, and Dr. Mark Gordon across hundreds of episodes.

In a 2018 episode with comedian Tom Segura, Rogan stated plainly that he uses testosterone and has for years, framing it as a medically supervised decision he made after blood work showed declining levels. He has described injecting testosterone and referenced using an aromatase inhibitor to manage estrogen conversion. In a 2021 conversation with Lex Fridman, he reiterated his use of TRT and characterized it as essential for maintaining his training output, recovery, and cognitive baseline as he aged past 50.

He has also publicly discussed using human growth hormone (HGH), though with less specificity about dosing or duration. His on-air mentions of BPC-157 (a synthetic peptide studied for tissue repair) and NAD+ infusions are frequent but anecdotal. He has referenced ipamorelin in the context of growth-hormone-releasing peptides during guest conversations, though he has not confirmed personal use of ipamorelin specifically. That distinction matters: discussing a compound on-air is not the same as disclosing personal use.

What is confirmed: TRT (injectable testosterone), HGH use, BPC-157 use, NAD+ infusions. What is publicly speculated but not confirmed by Rogan: specific ipamorelin use, specific dosing of any compound, whether he cycles or runs continuous protocols.

What a Standard TRT Protocol Looks Like

For a man in his mid-50s with documented low or declining testosterone (typically below 300 ng/dL on morning serum draws, or symptomatic in the 300 to 450 range), a prescribing clinician would follow guidelines consistent with the Endocrine Society's 2018 clinical practice guidelines.

A typical protocol includes:

Testosterone cypionate or enanthate, injected intramuscularly or subcutaneously at 100 to 200 mg per week (often split into twice-weekly injections to reduce peaks and troughs)
Monitoring labs at 6 to 12 week intervals initially, then every 6 to 12 months: total testosterone, free testosterone, estradiol, hematocrit, PSA, lipid panel, and liver function
Hematocrit management, because exogenous testosterone stimulates erythropoiesis. The FDA's labeling for testosterone products warns that hematocrit above 54% requires dose reduction or therapeutic phlebotomy
Estrogen management with an aromatase inhibitor (anastrozole 0.25 to 0.5 mg twice weekly) if estradiol rises above 40 to 50 pg/mL and the patient is symptomatic. Rogan has referenced using an AI, which is consistent with this approach

The goal is to bring total testosterone into the 600 to 900 ng/dL range, not to push supraphysiological levels. Clinics that target 1,200+ ng/dL are operating outside evidence-based practice, regardless of how the patient feels subjectively.

The HGH Question: Confirmed Use, Unconfirmed Protocol

Rogan has confirmed using growth hormone, but the clinical context is worth unpacking. Recombinant HGH (somatropin) is FDA-approved in adults only for documented growth hormone deficiency confirmed by stimulation testing, not for anti-aging or body composition optimization.

In clinical practice, anti-aging physicians prescribe HGH off-label at doses ranging from 0.5 to 2 IU per day, well below the 4 to 8 IU bodybuilders use. At low doses, expected effects include improved recovery, modest fat redistribution, and subjective improvements in sleep quality and skin elasticity. Side effects include fluid retention, joint stiffness, carpal tunnel symptoms, and insulin resistance. Long-term use carries theoretical concerns about cancer risk through IGF-1 elevation, though data in replacement-dose ranges remains inconclusive.

Growth-hormone-releasing peptides like ipamorelin and CJC-1295 are sometimes used as alternatives. These stimulate endogenous GH release rather than replacing it directly. Rogan has discussed these compounds during guest interviews but, as noted above, has not confirmed personal use of ipamorelin. The HealthRX Medical Team notes that these peptides are not FDA-approved for any indication and are currently in a regulatory gray zone, with the FDA issuing warnings about compounding pharmacy quality control.

BPC-157 and NAD+: The Peptide and Longevity Layer

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Rogan has spoken about using it for injury recovery on multiple episodes, describing it in practical terms as something that accelerated his healing from training-related issues.

The preclinical literature on BPC-157 is genuinely interesting. Rodent studies show accelerated tendon, ligament, and muscle healing through mechanisms involving nitric oxide modulation and growth factor upregulation. The critical limitation: there are zero completed human randomized controlled trials. Every claim about BPC-157 in humans is extrapolated from animal data or from anecdotal clinical use. The HealthRX Medical Team considers BPC-157 a compound with a promising preclinical signal and an absent clinical evidence base. That gap should be stated honestly, even when a high-profile user reports positive results.

NAD+ (nicotinamide adenine dinucleotide) infusions, which Rogan has mentioned receiving, are part of the longevity medicine toolkit. NAD+ is a coenzyme involved in cellular energy metabolism and DNA repair. Levels decline with age, and supplementation strategies (IV infusion, or oral precursors like NMN and NR) aim to restore youthful concentrations. Human data on IV NAD+ is limited to small trials showing improved metabolic markers. The infusions are expensive (typically $500 to $1,500 per session), uncomfortable (they cause intense flushing and nausea during administration), and of unproven long-term benefit.

The HealthRX Medical Team Take

Joe Rogan's influence on men's health decision-making is difficult to overstate. His podcast reaches an estimated 11 million listeners per episode, and his open discussion of TRT, HGH, and peptides has shifted the Overton window for hormone optimization in men over 40.

The HealthRX Medical Team sees both a benefit and a risk in this normalization. The benefit: men who would otherwise ignore declining testosterone, poor recovery, and low energy are now asking their doctors for blood work. That conversation is genuinely valuable. Testosterone deficiency is underdiagnosed and undertreated.

The risk: Rogan's audience often hears the enthusiasm without the clinical guardrails. TRT requires ongoing lab monitoring. It suppresses endogenous production and fertility (via hypothalamic-pituitary-gonadal axis suppression). Stopping TRT after long-term use without a structured PCT or taper can result in months of symptomatic hypogonadism. Polycythemia is a real and common complication that requires regular hematocrit checks. And HGH use without documented deficiency sits outside current evidence-based guidelines, regardless of how the patient subjectively feels.

The compounds Rogan discusses vary widely in their evidence quality. TRT sits on a solid foundation of randomized controlled trial data and society guidelines. HGH at anti-aging doses has moderate observational data. BPC-157 has preclinical data only. NAD+ infusions have limited early-phase human data. Collapsing all of these into a single "optimization stack" misrepresents the evidence hierarchy.

At a glance

TRT status: Confirmed by Rogan on multiple podcast episodes spanning over a decade
HGH status: Confirmed use, unconfirmed dosing or protocol details
BPC-157 status: Confirmed use for recovery purposes
NAD+ infusions: Confirmed use
Ipamorelin: Discussed on the podcast but personal use not confirmed
Clinical bottom line: TRT with proper monitoring is evidence-based medicine. The peptide and HGH layers require more rigorous human trial data before they can be recommended with equal confidence.

Frequently asked questions

›